Skip to main content

β-Hydroxybutyrate

CPT 82010
Synonyms
  • 3-Hydroxybutyrate (3HB)
  • Beta-Hydroxybutyric Acid
  • Ketone Bodies

Test Details

Methodology

Spectrophotometric

Result Turnaround Time

3 - 10 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Use

β-hydroxybutyrate is one of three sources of ketone bodies. Ketoacidosis in diabetes usually occurs with decreased plasma pH and bicarbonate, increased glucose, and other abnormalities. As ketoacidosis and metabolic acidosis are treated, hypokalemia may become evident. A normal or low potassium on admission with ketoacidosis may indicate severe potassium depletion.1 Thus, potassium is among parameters to follow in treatment of ketoacidosis. In children younger than 10 years of age, diabetic ketoacidosis is reported to account for 70% of diabetes-related deaths.2

Limitations

The β-hydroxybutyrate assay will not detect acetoacetic acid and acetone. Acidosis shifts equilibrium toward β-hydroxybutyrate, but treatment of ketoacidosis results in increased acetoacetate and a more positive "acetone" reaction before ketone bodies decrease.3

Specimen Requirements

Specimen

Serum (preferred) or plasma, frozen

Volume

1 mL

Minimum Volume

0.3 mL (Note: This volume does not allow for repeat testing.)

Container

Red-top tube, gel-barrier tube, lavender-top (EDTA) tube, or green-top (sodium heparin) tube.

Collection Instructions

Serum/plasma must be separated from cells within two hours of venipuncture. Transfer separated serum/plasma to a plastic transport tube. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.

Stability Requirements

Temperature

Period

Refrigerated

2 days

Frozen

11 days

Freeze/thaw cycles

Stable x3

Reference Range

All ages (fasting): 0.2−2.8 mg/dL

Storage Instructions

Freeze.

Patient Preparation

Fasting is preferred, but non-fasting samples are acceptable.

Causes for Rejection

Gross hemolysis

Footnotes

1. Bienia R, Ripoll I. Diabetic ketoacidosis. JAMA. 1979 Feb 2; 241(5):510-511. 104058
2. Bonadio WA, Gutzeit MF, Losek JD, Smith DS. Outpatient management of diabetic ketoacidosis. Am J Dis Child. 1988 Apr; 142(4):448-450. 3126645
3. Schade DS, Eaton RP. Differential diagnosis and therapy of hypoketonemic state. JAMA. 1979 May 11; 241(19):2064-2065. 107340

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
503610 Beta-Hydroxybutyrate 29512-1 503611 Beta-Hydroxybutyrate mg/dL 29512-1
Order Code503610
Order Code NameBeta-Hydroxybutyrate
Order Loinc29512-1
Result Code503611
Result Code NameBeta-Hydroxybutyrate
UofMmg/dL
Result LOINC29512-1